Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of ASP1707 and Methotrexate in Patients With Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study evaluating ASP1707 in combination with Methotrexate in patients with rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ASP1707
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED